Join us for this year’s International Pathology Day on the theme ‘Advances in rapid and point-of-care diagnostic testing’.

The day will include workshops, presentations from key note speakers and a roundtable discussion with global experts in conjunction with The Pathologist, besides more.

The event will take place at the new College building in central London.

More details about the event and the programme will be released nearer the time. Look out for more information over the coming months.  See the programme for more details and the Roundtable topic will be 'A question of quality.'

Full day event attendance is worth four CPD credits.




09.30 – 10.15  Registration & refreshments for full-day participants

10.15 – 10.25  Welcome from the President of the Royal College of Pathologists

10.25 – 10.55  Mr Tony Cambridge, Advances in rapid and point of care diagnostics testing

10.55 – 11.25  Dr Charles van Heyningen, Recent point of care diagnostic developments in Eastern and Southern Africa 

11.25. – 11.45  Refreshments

11.45 – 12.15  Mrs Annette Wilkinson & Dr Gillian Holdsworth, The Doctors Laboratory (TDL) Tinies TM Self collection

12.15 – 12.45  Professor Tahir Pillay, New diagnostic probes for point-of-care diagnostic testing (POCT)

12.45 – 13.45  Lunch including sponsored workshop and poster competition judging

13.00 – 13.15  Poster competition judging (Outside Elizabeth Room 1st floor)

13.15 – 13.45  Sponsored lunchtime workshop, A Day in the Life of an Augmented Pathologist (Carlton Room 2nd floor)

Find out more about the augmented pathologist workshop

Artificial intelligence and machine learning are no longer “hype.” We have seen the effects of AI in other fields already, and we all have some understanding of AI – but what does it mean when put into the context of pathology?

With the promise of AI augmenting pathologists, enabling effectiveness and efficiency by taking over day-to-day tasks, offering performance with higher quality, and better safety - it is clear that significant changes are underway. The big question is, how quickly will it happen?

It needs validation studies, changes in workflows, proper infrastructure, etc. to be successful, but pathologists now understand what this promise holds.

In this workshop, we will explore the pros and cons of artificial intelligence in healthcare, specifically pathology, and put this into the context of everyday life of a pathologist, highlighting both the negative and positive impacts.

13.45 – 13.55  Audience seated for roundtable

14:00 – 15.15  Roundtable: A question of quality

15.20 – 15.25  Winning poster announced

15:25 – 15.30  Closing remarks

15:30 – 17.30 Leica Biosystems launch their Future of Pathology project, followed by networking and refreshments (Elizabeth Room 1st floor)


Registration Fees

Members: £70.00

Concessional: £40.00 – Includes trainees, BMS, non-consultant Clinical Scientists, retired & nurses

Non-members: £100.00




To be held at The Royal College of Pathologists, 6 Alie Street, London, E1 8QT

Event speakers

IPD 2019 key-note speakers, round-table panellists and lunchtime workshop lead facilitator

  • Mrs Annette Willkinson

    Director of Business Development and Service at The Doctors Laboratory

    Annette joined The Doctors Laboratory in 1989, and has been closely involved  in the growth and change from very small, to larger organisation. Annette has benefited from the developments in clinical diagnostics where scope of service and introduction of new diagnostic assays, supported by technical and IT delivery have provided opportunity for innovative development  and change.  She believes the formula for successful personal and business development is maintained by keeping the outward facing business message simple whilst benefiting from talented colleagues  who have helped with the complex internal execution and delivery.  Everyone has a role to play in service and operational delivery.

  • Dr Charles Van Heyningen

    Former International advisor at the Royal College of Pathologists

    After an education in South Africa and Western Europe, I trained in biochemistry, medicine and chemical pathology in London. I worked as a consultant pathologist in Liverpool where I gained experience of point of care testing including an evaluation of using a near patient analyser in the emergency department. As international regional advisor, I have been involved with the College’s international developments which have included laboratory skills training in Eastern Africa.

  • Lt Col (Dr) Emma Hutley

    Defence Medical Services

    Lieutenant Colonel Emma Hutley (MSc MRCP FRCPath DTM&H RAMC) is a Consultant Clinical Microbiologist and Defence Consultant Advisor In Pathology. She joined the British Army in 1997 and has served in Germany, Kenya, Poland, Iraq and Afghanistan. Appointed Consultant Microbiologist in 2013, she undertakes regular NHS clinical duties at Frimley Park Hospital. In 2014 she was appointed Defence Consultant Advisor in Pathology and leads the Centre of Defence Pathology. She is responsible for deploying laboratories, blood transfusion, and diagnostic services across the globe, including on ships and aircraft. She has a keen interest in emerging diagnostic capability and how it can transform patient care.


  • Dr Gillian Holdsworth

    Managing Director at SH:24

    Gillian is a public health expert and director of SH:24 – an online sex and reproductive health service developed in partnership with the NHS. Using design-led innovation, SH:24 seeks to promote self-management and improve the sexual health of the local population. Since introduction, SH:24 has doubled access to STI testing and reduced STI rates by 8%.  SH:24 was awarded the BMJ Innovation team award in 2017; the Digital Impact award (health), the Queen's award for enterprise (innovation category) and the Guardian public service award in digital and technology in 2018. 

  • Professor Jo Martin

    President of the Royal College of Pathologists

    Jo has very broad experience in healthcare management ranging from running clinical departments and divisions to acting as Medical Director and Chief Medical Officer at Barts Health NHS Trust. As Director of Academic Health Sciences she has led research across the Trust and the training and education of 16,000 staff across Barts Health. 

    National Clinical Director of Pathology for NHS England April 2013-16, Jo has worked across a broad range of programmes and projects in all the pathology disciplines including genetics, transfusion, digital pathology, data, networks and working with the diagnostic professional bodies, including the Academy of Medical Royal Colleges.

    She is involved in a range of bodies as a board member, including chairing the Research Advisory Board of the Motor Neuron Disease Association and Chairing the Strategic Clinical Reference Group of the National Information Board.

    Jo became President of the Royal College of Pathologists in November 2017.

  • Mr Martin Kristensson

    Senior Vice President at Visiopharm A/S

    Martin Kristensson is Senior Vice President, responsible for sales in Europe, leading the EU based sales team. He received his M.Sc. in Biomedical Engineering from the Technical University of Denmark in 2011, specialising in Signal and Model-based Diagnostics, combined with Image Diagnostics and Radiation Physics.  Together with his team, he coordinated the development of Visiopharm’s clinical products, and the change management processes used to implement the tools in the daily clinical routine across Denmark. In close collaboration with colleagues and customers, he continues to investigate new applications of image analysis within pathology, pursuing new ways of offering standardised high-quality data and diagnosis.

  • Professor Tahir Pillay

    Professor & Chair at the University of Pretoria

    Professor Tahir Pillay is Professor and Head, Department of Chemical Pathology, University of Pretoria,  South Africa; Editor-in-Chief, Journal of Clinical Pathology; chair of the Communications Division, International Federation of Clinical Chemistry (IFCC) and President of the South African Association for Clinical Biochemistry. He has an MBChB (University of Natal) ,PhD in biochemistry (University of Cambridge) and trained at Hammersmith Hospital, Imperial College, London and the University of California San Diego. He is a Fellow of the RCPath. He is pioneering the use of nanobodies in clinical laboratory diagnostics and point-of-care testing with new robust low-cost immunoassay methodology.

  • Mr Tony Cambridge

    Lead Biomedical at University Hospitals Plymouth NHS Trust

    I am currently Lead Healthcare Scientist as part of the management team of a busy multidisciplinary blood sciences department in Plymouth. My background is clinical chemistry but I spent almost 10 years leading the POCT team. I am an advocate of POCT when delivered as part of a well governed and adequately resourced service. I chair conferences and speak regularly covering topics such as POCT, automation and management and I am a member of an international scientific advisory committee. In March 2018 I set up Thornhill Healthcare Events Ltd. to provide educational events that were more accessible and affordable for staff in the NHS and other healthcare organisations.

  • Dr Wale Atoyebi

    Consultant Haematologist Lead Clinician for red cell disorders at the Oxford University Hospitals NHS Foundation Trust Oxford

    Dr Wale Atoyebi is a Consultant Haematologist, lead clinician for red cell disorders at the Oxford University Hospitals NHS Foundation Trust, Oxford and honorary senior clinical lecturer at Oxford University. He underwent his haematology training in Oxford. His main interests are haemoglobinopathies and disorders of iron metabolism including diagnostics utilising an Oxford NGS iron regulatory panel. He is member of the NHS England, Clinical Reference Group for Haemoglobinopathies and on the editorial board of the 2018 Standards For The Clinical Care Of Adults With SCD in the UK. He is also involved in collaborative research focused on strengthening healthcare systems by improving best practice in the diagnostics and management of SCD in sub-Saharan Africa. Recently appointed Royal College of Pathologists (UK) - clinical lead for the EU - H2020-MSCA-RISE-2018 (ARISE) program.